Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.

Keu KV, Witney TH, Yaghoubi S, Rosenberg J, Kurien A, Magnusson R, Williams J, Habte F, Wagner JR, Forman S, Brown C, Allen-Auerbach M, Czernin J, Tang W, Jensen MC, Badie B, Gambhir SS.

Sci Transl Med. 2017 Jan 18;9(373). pii: eaag2196. doi: 10.1126/scitranslmed.aag2196.

2.

Detecting Tumor Metastases: The Road to Therapy Starts Here.

Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB.

Adv Cancer Res. 2016;132:1-44. doi: 10.1016/bs.acr.2016.07.001. Epub 2016 Aug 17. Review.

3.

Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.

Park JH, Kim KI, Lee KC, Lee YJ, Lee TS, Chung WS, Lim SM, Kang JH.

Cancer Biother Radiopharm. 2015 Feb;30(1):8-15. doi: 10.1089/cbr.2014.1716. Epub 2014 Dec 29.

4.

Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs).

Liu Z, Li Z.

Theranostics. 2014 Jul 28;4(10):990-1001. doi: 10.7150/thno.9268. eCollection 2014. Review.

5.

A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions.

Xing L, Sun X, Deng X, Kotedia K, Zanzonico PB, Ackerstaff E, Koutcher JA, Ling CC, Li GC.

Cancer Gene Ther. 2013 Jun;20(6):358-65. doi: 10.1038/cgt.2013.28. Epub 2013 May 31.

6.

Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage.

Penet MF, Chen Z, Li C, Winnard PT Jr, Bhujwalla ZM.

Drug Deliv Transl Res. 2012 Feb 1;2(1):22-30. doi: 10.1007/s13346-011-0052-0.

7.

An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides.

Zhang H, Cantorias MV, Pillarsetty N, Burnazi EM, Cai S, Lewis JS.

Nucl Med Biol. 2012 Nov;39(8):1182-8. doi: 10.1016/j.nucmedbio.2012.06.008. Epub 2012 Jul 18.

8.

Molecular imaging with activatable reporter systems.

Niu G, Chen X.

Theranostics. 2012;2(4):413-23. doi: 10.7150/thno.3940. Epub 2012 Apr 12.

9.

Magnetic resonance reporter gene imaging.

Lee SW, Lee SH, Biswal S.

Theranostics. 2012;2(4):403-12. doi: 10.7150/thno.3634. Epub 2012 Apr 12.

10.

Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.

Yaghoubi SS, Campbell DO, Radu CG, Czernin J.

Theranostics. 2012;2(4):374-91. doi: 10.7150/thno.3677. Epub 2012 Apr 10.

11.

Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.

Ardiani A, Johnson AJ, Ruan H, Sanchez-Bonilla M, Serve K, Black ME.

Curr Gene Ther. 2012 Apr 1;12(2):77-91. Review.

12.

Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma.

Varma NR, Janic B, Iskander AS, Shankar A, Bhuiyan MP, Soltanian-Zadeh H, Jiang Q, Barton K, Ali MM, Arbab AS.

PLoS One. 2012;7(1):e30310. doi: 10.1371/journal.pone.0030310. Epub 2012 Jan 20.

13.

Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.

Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A, Radu CG, Galic Z, Zack JA.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):E1408-16. doi: 10.1073/pnas.1115050108. Epub 2011 Nov 28.

14.

A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.

Likar Y, Zurita J, Dobrenkov K, Shenker L, Cai S, Neschadim A, Medin JA, Sadelain M, Hricak H, Ponomarev V.

J Nucl Med. 2010 Sep;51(9):1395-403. doi: 10.2967/jnumed.109.074344.

15.

Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.

Koya RC, Mok S, Comin-Anduix B, Chodon T, Radu CG, Nishimura MI, Witte ON, Ribas A.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14286-91. doi: 10.1073/pnas.1008300107. Epub 2010 Jul 12.

16.

In Vivo Cellular Imaging for Translational Medical Research.

Arbab AS, Janic B, Haller J, Pawelczyk E, Liu W, Frank JA.

Curr Med Imaging Rev. 2009 Feb 1;5(1):19-38.

17.

Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.

Johnson M, Karanikolas BD, Priceman SJ, Powell R, Black ME, Wu HM, Czernin J, Huang SC, Wu L.

J Nucl Med. 2009 May;50(5):757-64. doi: 10.2967/jnumed.108.058438. Epub 2009 Apr 16.

18.

In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods.

Kraitchman DL, Bulte JW.

Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1025-30. doi: 10.1161/ATVBAHA.108.165571. Epub 2009 Apr 9. Review.

19.

Molecular imaging as a tool for translating breast cancer science.

Mankoff DA.

Breast Cancer Res. 2008;10 Suppl 1:S3. doi: 10.1186/bcr2126. Epub 2008 Dec 9. Review.

20.

Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells.

Leiker M, Suzuki G, Iyer VS, Canty JM Jr, Lee T.

Cell Transplant. 2008;17(8):911-22.

Supplemental Content

Support Center